COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients

Hematol Oncol. 2023 Aug;41(3):559-562. doi: 10.1002/hon.3121. Epub 2023 Jan 9.

Authors

Giovanni Del Poeta¹, Roberta Laureana¹, Riccardo Bomben², Francesca Maria Rossi², Federico Pozzo², Eva Zaina², Ilaria Cattarossi², Paola Varaschin², Paola Nanni², Romina Boschian Boschin³, Andrea Nunzi¹, Massimiliano Postorino¹, Gianmario Pasqualone¹, Giulia Brisotto³, Agostino Steffan³, Elena Muraro³, Antonella Zucchetto², Maria Ilaria Del Principe¹, Valter Gattei²

Affiliations

¹ Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
² Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
³ Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Immunity, Cellular
Leukemia, Lymphocytic, Chronic, B-Cell* / therapy
Vaccination

Substances

COVID-19 Vaccines

Grants and funding